Karo Pharma AB | Cash Flow
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
22,258.00
59,455.00
74,863.00
29,573.00
79,904.00
414,320
Depreciation, Depletion & Amortization
1,434.00
1,867.00
3,153.00
21,937.00
63,136.00
217,653
Other Funds
4,313.00
-
1,500.00
1,561.00
-
158,334
Funds from Operations
20,691.00
57,392.00
67,036.00
5,654.00
90,186.00
473,639
Changes in Working Capital
12,698.00
11,062.00
14,825.00
41,772.00
56,667.00
155,608
Net Operating Cash Flow
33,389.00
46,330.00
52,211.00
36,118.00
33,519.00
318,031
Capital Expenditures
2,245.00
1,483.00
261.00
69,888.00
7,796.00
Sale of Fixed Assets & Businesses
-
-
-
144.00
397.00
Purchase/Sale of Investments
26,096.00
14.00
6.00
-
-
Net Investing Cash Flow
23,851.00
1,497.00
220,837.00
995,927.00
1,245,814.00
Cash Dividends Paid - Total
-
-
-
-
41,083.00
Issuance/Reduction of Debt, Net
-
-
67,055.00
819,945.00
1,007,351.00
Net Financing Cash Flow
4,313.00
76,637.00
297,929.00
1,076,402.00
1,931,054.00
Net Change in Cash
5,225.00
28,810.00
24,881.00
44,856.00
717,240.00
Free Cash Flow
35,634.00
47,813.00
52,472.00
44,954.00
29,798.00
Net Assets from Acquisitions
-
-
220,570.00
926,183.00
1,256,086.00
Other Sources
-
-
-
-
17,786.00
Change in Capital Stock
-
76,637.00
232,374.00
258,018.00
964,786.00
Exchange Rate Effect
-
-
-
499.00
1,519.00
Other Uses
-
-
-
-
115.00
About Karo Pharma AB
View Profile
